Shanghai Haishun New Pharmaceutical Packaging stated on the investor interaction platform that the company will continue to perform well in its performance, strengthen communication with investors, enhance communication with the capital markets, promptly convey the operational status, strategic direction, and market layout, implement share repurchases, cash dividends, and other work, boost market confidence, actively screen and evaluate potential acquisition targets around the needs of extending the core business, complementing technology, and expanding the market, promote outward development, strengthen market cap management with multiple measures, reward investors' support, thank you for your attention and suggestions.
海顺新材:围绕主业延伸、技术补充以及市场扩张需求,积极筛选评估潜在收购目标
Shanghai Haishun New Pharmaceutical Packaging: Actively screen and assess potential acquisition targets around the core business extension, technology complement, and market expansion needs.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.